KALARIS THERAPEUTICS INC (KLRS) Forecast, Price Target & Analyst Ratings

NASDAQ:KLRS • US4829291065

Current stock price

5.86 USD
-0.26 (-4.25%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for KALARIS THERAPEUTICS INC (KLRS).

Forecast Snapshot

Consensus Price Target

Price Target
$18.97
+ 223.75% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 12, 2026
Period
Q4 / 2025
EPS Estimate
-$0.54
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
85.00%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$18.97
Upside
+ 223.75%
From current price of $5.86 to mean target of $18.97, Based on 12 analyst forecasts
Low
$5.05
Median
$20.40
High
$27.30

Price Target Revisions

1 Month
0.00%
3 Months
9.41%

Price Target Summary

12 Wall Street analysts provided a forecast for the next 12 months for KLRS. The average price target is 18.97 USD. This implies a price increase of 223.75% is expected in the next year compared to the current price of 5.86.
The average price target has been revised upward by 9.41% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

KLRS Current Analyst RatingKLRS Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4

Analyst Ratings History

KLRS Historical Analyst RatingsKLRS Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
85.00%
KLRS was analyzed by 12 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about KLRS.
In the previous month the buy percentage consensus was at a similar level.
KLRS was analyzed by 12 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2025-12-23Chardan CapitalInitiate Buy
2025-11-03CitizensInitiate Market Outperform
2025-09-03Raymond JamesInitiate Strong Buy
2025-04-08William BlairInitiate Outperform

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 12, 2026
Period
Q4 / 2025
EPS Estimate
-$0.54
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
-624.81%
Number of Analysts
8

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
19.88%

Next Earnings Summary

KLRS is expected to report earnings on 5/12/2026. The consensus EPS estimate for the next earnings is -0.54 USD and the consensus revenue estimate is 0 USD.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2025 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
KLRS revenue by date.KLRS revenue by date.
1.14M170K
-85.09%
-100.00%		390.15K13.6M
-100.00%		6.656M22.329M
235.47%		85.803M
284.27%		189.55M
120.91%		396.61M
109.24%
EBITDA
YoY % growth
KLRS ebitda by date.KLRS ebitda by date.
-3.6M-26.68M
-641.11%		-73.44M
-167.02%		-166.26M
-138.11%		-176.978M
-0.50%		-192.667M
-5.94%		-70.115M
61.18%		-55.995M
20.14%		-62.525M
-11.66%		N/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
KLRS ebit by date.KLRS ebit by date.
-3.6M-26.7M
-641.67%		-75.066M
-167.08%		-169.409M
-138.14%		-184.517M
-0.81%		-189.785M
-5.72%		-65.032M
69.61%		-49.782M
9.49%		-57.567M
-15.64%		-66.352M
-15.26%		-122.394M
-84.46%		-120.667M
1.41%		-141.723M
-17.45%		-165.183M
-16.55%		-103.032M
37.63%		35.744M
134.69%
Operating Margin
KLRS operating margin by date.KLRS operating margin by date.
-315.79%-15,705.88%N/A-43,421.52%N/AN/AN/AN/AN/A-487.88%N/A-1,812.90%-634.70%-192.51%-54.36%9.01%
EPS
YoY % growth
KLRS eps by date.KLRS eps by date.
N/AN/A-105.96-61.86
40.53%		-52.71
17.88%		-40.96
25.78%		-0.51
98.68%		-3.77
-644.22%		-2.53
32.88%		-1.63
35.41%		-2.54
-55.70%		-1.92
24.55%		-1.97
-2.66%		-2.10
-6.77%		-1.06
49.44%		0.60
156.55%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27 Q1 / 28 Q2 / 28 Q3 / 28
EPS
Q2Q % growth		-0.54
-624.81%		-0.64
74.47%		-0.65
-6.93%		-0.64
-0.53%		-0.60
-10.58%		-0.46
28.34%		-0.75
-14.78%		-0.90
-39.99%		-1.05
-75.75%		-1.20
-161.28%		-1.36
-81.06%		-1.50
-67.04%
Revenue
Q2Q % growth		N/AN/AN/A
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-13.706M
29.80%		-14.154M
-36.70%		-14.7M
-19.94%		-15.282M
-19.94%		-15.901M
-16.01%		N/AN/AN/AN/AN/AN/AN/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

KLRS Yearly Revenue VS EstimatesKLRS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2021 2027 2029 2030 2031 2032 2033 100M 200M 300M
KLRS Yearly EPS VS EstimatesKLRS Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 -20 -40 -60 -80 -100

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
-47.76%
EPS Next 5 Year
-30.54%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

KALARIS THERAPEUTICS INC / KLRS Forecast FAQ

What is the average price target for KALARIS THERAPEUTICS INC (KLRS) stock?

12 analysts have analysed KLRS and the average price target is 18.97 USD. This implies a price increase of 223.75% is expected in the next year compared to the current price of 5.86.

When does KALARIS THERAPEUTICS INC (KLRS) report earnings?

KALARIS THERAPEUTICS INC (KLRS) will report earnings on 2026-05-12.

What are the consensus estimates for KLRS stock next earnings?

The consensus EPS estimate for the next earnings of KALARIS THERAPEUTICS INC (KLRS) is -0.54 USD and the consensus revenue estimate is 0 USD.

How do analysts rate KALARIS THERAPEUTICS INC (KLRS)?

The consensus rating for KALARIS THERAPEUTICS INC (KLRS) is 85 / 100 . This indicates that analysts generally have a positive outlook on the stock.